Rix-Fp, a Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin, Improves Kinetics in Cynomolgus Monkeys and Hemophilia B Dogs

被引：0
|
作者：
Nolte, Marc Wolfgang [1 ]
Nichols, Timothy Charles [2 ]
Mueller-Cohrs, Jochen [1 ]
Merricks, Elizabeth Parker [2 ]
Pragst, Ingo [1 ]
Zollner, Sabine [1 ]
Dickneite, Gerhard [1 ]
机构：
[1] CSL Behring GmbH, Preclin Res & Dev, Marburg, Germany
[2] Univ N Carolina, Dept Pathol & Lab Med, Francis Owen Blood Res Lab, Chapel Hill, NC USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2012年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S176 / S176
页数：1
相关论文
共 50 条
  • [41] IDEAL study: A real-world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX-FP) in patients with haemophilia B in Italy
    Tagliaferri, Annarita
    Molinari, Angelo Claudio
    Peyvandi, Flora
    Coppola, Antonio
    Demartis, Francesco
    Biasoli, Chiara
    Borchiellini, Alessandra
    Cultrera, Dorina
    De Cristofaro, Raimondo
    Daniele, Filomena
    Giordano, Paola
    Marchesini, Emanuela
    Margaglione, Maurizio
    Marino, Renato
    Pollio, Berardino
    Radossi, Paolo
    Santoro, Cristina
    Santoro, Rita Carlotta
    Siragusa, Sergio
    Sottilotta, Gianluca
    Tosetto, Alberto
    Piscitelli, Lydia
    Villa, Maria Rosaria
    Zanon, Ezio
    Finardi, Adele
    Schiavetti, Irene
    Vaccari, Daniella
    Castaman, Giancarlo
    HAEMOPHILIA, 2023, 29 (01) : 135 - 144
  • [42] Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP
    Davis, Joanna
    Yan, Songkai
    Matsushita, Tadashi
    Alberio, Lorenzo
    Bassett, Paul
    Santagostino, Elena
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (10) : 1014 - 1021
  • [43] Pharmacokinetic (PK) Results of Two Phase III Clinical Studies of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (RIX-FP) in Previous Treated Patients with Haemophilia B (PROLONG-9fp)
    Santagostino, E.
    Jacobs, I.
    Voigt, C.
    Feussner, A.
    Limsakun, T.
    HAEMOPHILIA, 2015, 21 : 27 - 28
  • [44] Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Children < 12 Years of Age with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial
    Kenet, Gili
    Brainsky, Andres
    Powell, Jerry S.
    Li, Yanyan
    Seifert, Wilfried
    BLOOD, 2017, 130
  • [45] Biodistribution of the recombinant fusion protein linking factor rIX with albumin
    Herzog, Eva
    Schenk, Sabrina
    Nolte, Marc W.
    Harris, Stephen
    Mcewen, Andrew
    Pragst, Ingo
    Dickneite, Gerhard
    Schulte, Stefan
    Zollner, Sabine
    HAEMOPHILIA, 2014, 20 : 23 - 23
  • [46] Prolonged serum half-life of a recombinant, albumin-fused, human coagulation factor IX (rIX-FP) in different animal species
    Metzner, H.
    Weimer, T.
    Raquet, E.
    Nolte, W. M.
    Pragst, I.
    Zollner, S.
    HAEMOPHILIA, 2010, 16 : 40 - 40
  • [47] Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX-Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective-Prospective Study
    Coppola, Antonio
    Rivolta, Gianna Franca
    Quintavalle, Gabriele
    Matichecchia, Annalisa
    Riccardi, Federica
    Rossi, Rossana
    Benegiamo, Anna
    Ranalli, Paola
    Coluccio, Valeria
    Tagliaferri, Annarita
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [48] Bleeding Risk Reduction in Relation to Predicted Factor IX Levels in Hemophilia B Patients Receiving Idelvion (rIX-FP)
    Roberts, John
    Fosser, Cecilia
    Tortorici, Michael
    Veldman, Alex
    Jacobs, Iris C.
    Sidhu, Jagdev
    BLOOD, 2016, 128 (22)
  • [49] Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis
    Cedric Hermans
    Renato Marino
    Catherine Lambert
    Sarah Mangles
    Patrick Sommerer
    Vincent Rives
    Geraldine Maro
    Giuseppe Malcangi
    Advances in Therapy, 2020, 37 : 2988 - 2998
  • [50] Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis
    Hermans, Cedric
    Marino, Renato
    Lambert, Catherine
    Mangles, Sarah
    Sommerer, Patrick
    Rives, Vincent
    Maro, Geraldine
    Malcangi, Giuseppe
    ADVANCES IN THERAPY, 2020, 37 (06) : 2988 - 2998
12345